Please login to the form below

Not currently logged in


This page shows the latest Lenvima news and features for those working in and with pharma, biotech and healthcare.

Eisai’s Lenvima wins European liver cancer indication

Eisai’s Lenvima wins European liver cancer indication

Eisai’ s Lenvima wins European liver cancer indication. EC green-lights the RTK inhibitor as a first-line treatment. ... Additionally, Lenvima also demonstrated statistically significant superiority and clinically meaningful improvements compared to

Latest news

More from news
Approximately 9 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...